US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist
  • 1.150
  • +0.070+6.48%
Close May 3 16:00 ET
  • 1.140
  • -0.010-0.87%
Post 19:30 ET
193.13MMarket Cap-2017P/E (TTM)

X4 Pharmaceuticals Key Stats

X4 Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 21, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.09

+68.97%

Buy

Apr 30, 2024

X4 Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 15.197M--
--2024/Q1-- / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
Aug 10, 20232023/Q20.000 / 0.000--
May 4, 20232023/Q10.000 / 0.000--
Mar 21, 20232022/Q40.000 / 0.000--
Nov 3, 20222022/Q30.000 / 0.000--
Aug 4, 20222022/Q20.000 / 0.000--
May 12, 20222022/Q10.000 / 106.250K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 15.197M--
--2024/Q1-- / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
Aug 10, 20232023/Q20.000 / 0.000--
May 4, 20232023/Q10.000 / 0.000--
Mar 21, 20232022/Q40.000 / 0.000--
Nov 3, 20222022/Q30.000 / 0.000--
Aug 4, 20222022/Q20.000 / 0.000--
May 12, 20222022/Q10.000 / 106.250K--

Unlock Free Earnings Estimates

X4 Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg